Salvina Therapeutics is developing antibodies with a novel approach for targeting TNF and TNF superfamily members with the aim of improving their safety and efficacy, and facilitating the generation of novel bispecific therapies.
Member of the Swiss Biotech Association
Member
Salvina Therapeutics AG
Salvina Therapeutics AG
Verified listing
-
Founded2023
-
Employees in Switzerland1-9
- Send an email
- Get directions
- Bookmark
- Share
- Report
- prev
- next